Literature DB >> 33481161

Rehabilitation interventions for the management of breast cancer-related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship.

Kathryn Ryans1, Marisa Perdomo2, Claire C Davies3, Kimberly Levenhagen4, Laura Gilchrist5.   

Abstract

PURPOSE: A work group from the American Physical Therapy Association Academy of Oncologic Physical Therapy developed and published a clinical practice guideline (CPG) to aid clinicians in identifying interventions for individuals with breast cancer-related lymphedema (BCRL). This guideline reviewed the evidence for risk mitigation and volume reduction beginning at cancer diagnosis and continuing through survivorship. Application of CPGs can be challenging due to the variability of clinical settings, heterogeneous patient populations, and range of rehabilitation clinician expertise. The purpose of this paper is to assist these clinicians in implementing the recommendations from the CPG to develop a patient-centered, evidence-based plan of care. METHODS/
RESULTS: This publication presents important considerations for the implementation of recommended rehabilitation interventions across the trajectory of BCRL.
CONCLUSION: Current evidence supports specific interventions to treat or mitigate the risk for the various stages of BCRL. As clinicians implement these recommendations into practice, they also need to address other impairments that may exist in every individual. Continued collaboration between clinicians and researchers is necessary to further develop optimal treatment modalities and parameters. IMPLICATIONS FOR CANCER SURVIVORS: By implementing evidence-based interventions as outlined in the CPG, clinicians can improve the quality of care for survivors of breast cancer.

Entities:  

Keywords:  Breast cancer; Interventions; Lymphedema

Year:  2021        PMID: 33481161     DOI: 10.1007/s11764-021-00991-2

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  51 in total

1.  Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.

Authors:  Chirag Shah; Frank A Vicini
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-09-22       Impact factor: 7.038

2.  Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care.

Authors:  Nicole L Stout; Lucinda A Pfalzer; Barbara Springer; Ellen Levy; Charles L McGarvey; Jerome V Danoff; Lynn H Gerber; Peter W Soballe
Journal:  Phys Ther       Date:  2011-09-15

Review 3.  Lymphedema: strategies for management.

Authors:  S R Cohen; D K Payne; R S Tunkel
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

4.  The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.

Authors:  Atilla Soran; Tolga Ozmen; Kandace P McGuire; Emilia J Diego; Priscilla F McAuliffe; Marguerite Bonaventura; Gretchen M Ahrendt; Lori DeGore; Ronald Johnson
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

5.  Preoperative assessment enables the early diagnosis and successful treatment of lymphedema.

Authors:  Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

6.  Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.

Authors:  Kristin L Campbell; Kerri M Winters-Stone; Joachim Wiskemann; Anne M May; Anna L Schwartz; Kerry S Courneya; David S Zucker; Charles E Matthews; Jennifer A Ligibel; Lynn H Gerber; G Stephen Morris; Alpa V Patel; Trisha F Hue; Frank M Perna; Kathryn H Schmitz
Journal:  Med Sci Sports Exerc       Date:  2019-11       Impact factor: 5.411

7.  Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study.

Authors:  Rehana L Ahmed; Anna Prizment; DeAnn Lazovich; Kathryn H Schmitz; Aaron R Folsom
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

Review 8.  Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Phys Ther       Date:  2017-07-01

9.  Interventions for Breast Cancer-Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA.

Authors:  Claire Davies; Kimberly Levenhagen; Kathryn Ryans; Marisa Perdomo; Laura Gilchrist
Journal:  Phys Ther       Date:  2020-07-19

10.  Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.

Authors:  Louise A Koelmeyer; Robert J Borotkanics; Jessica Alcorso; Philip Prah; Caleb J Winch; Kristine Nakhel; Catherine M Dean; John Boyages
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

View more
  3 in total

1.  Upper limb rehabilitation system based on virtual reality for breast cancer patients: Development and usability study.

Authors:  Zijun Zhou; Jiaxin Li; He Wang; Ze Luan; Yuan Li; Xin Peng
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

Review 2.  Surgical Treatment and Rehabilitation Strategies for Upper and Lower Extremity Lymphedema: A Comprehensive Review.

Authors:  Alessandro de Sire; Luigi Losco; Lorenzo Lippi; Davide Spadoni; Juste Kaciulyte; Gokhan Sert; Paola Ciamarra; Marco Marcasciano; Roberto Cuomo; Alberto Bolletta; Marco Invernizzi; Emanuele Cigna
Journal:  Medicina (Kaunas)       Date:  2022-07-19       Impact factor: 2.948

Review 3.  Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health-a Scoping Review.

Authors:  Monica Pinto; Dario Calafiore; Maria Carmela Piccirillo; Massimo Costa; Ozden Ozyemisci Taskiran; Alessandro de Sire
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.